Company Filing History:
Years Active: 2022-2023
Title: The Innovative Contributions of Ki-Moon Park
Introduction
Ki-Moon Park is a notable inventor based in Seongnam-si, South Korea. He has made significant strides in the field of biotechnology with a focus on antibody compositions that play a crucial role in diagnosing diseases. With a total of three patents to his name, Park continues to push the boundaries of medical research and innovation.
Latest Patents
Ki-Moon Park's latest inventions include two patents for an antibody composition specifically recognizing an immunogenic fragment peptide of the EN2 protein. This innovation relates to a method for quantifying the EN2 protein through the specific recognition of its peptide. The antibody prepared using this peptide demonstrates vastly superior detection sensitivity when compared to existing EN2 protein antibodies. This capability renders it a potentially valuable diagnostic agent for prostate cancer, highlighting Park's commitment to improving diagnostic tools in the medical field.
Career Highlights
Currently, Ki-Moon Park is affiliated with Sung Kyun Biotech Co., Ltd., where he collaborates with fellow researchers to drive advancements in biotechnological applications. His work has garnered attention for its applicability in clinical diagnostics, particularly concerning cancer detection.
Collaborations
Throughout his career, Ki-Moon Park has worked closely with colleagues such as Kyeong-Nam Yu and Eun-Yi Cho. Together, they have fostered a research environment that encourages innovation and the development of new biotechnological solutions.
Conclusion
In summary, Ki-Moon Park stands out as an influential inventor whose work significantly impacts the medical diagnostic landscape. With his innovative antibody compositions, he is paving the way for advancements in prostate cancer diagnosis, emphasizing the importance of research and collaboration in the field of biotechnology.